Endovia Health Sciences (EDVA) EBIT Margin Growth (3y) (2015 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) EBIT Margin Growth (3y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.50 Bn | 133.65 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 65.05 Bn | 59.86 Bn | 1.37 Bn | 7,045.00 |
| 4 | Moderna | 57.11 Bn | 51.98 Bn | 52.00 Mn | -1,934.00 |
| 5 | Revolution Medicines | 44.71 Bn | 44.71 Bn | - | - |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 7,261.00 |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn | 9,003.00 |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | -2,649.00 |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 30,461.00 |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -2.31 Mn |
| Dec 31, 2025 | 36,692.00 |
| Sep 30, 2025 | -232,329.00 |
| Jun 30, 2025 | 654,669.00 |
| Mar 31, 2025 | -227,238.00 |
| Dec 31, 2024 | 23,482.00 |
| Sep 30, 2024 | 13,731.00 |
| Jun 30, 2024 | -15,735.00 |
| Mar 31, 2024 | -330.00 |
| Dec 31, 2023 | 111,210.00 |
| Sep 30, 2023 | 22,814.00 |
| Jun 30, 2023 | 1,941.00 |
| Mar 31, 2023 | 132,379.00 |
| Dec 31, 2022 | -916,581.00 |
| Sep 30, 2022 | 17,737.00 |
| Jun 30, 2022 | 59,083.00 |
| Mar 31, 2022 | 1.67 Mn |
| Dec 31, 2021 | -21,912.00 |
| Sep 30, 2021 | -40,850.00 |
| Jun 30, 2021 | -21,455.00 |